In August 2018, a California jury agreed with groundskeeper Dewayne Johnson’s assertion that Bayer AG and their subsidiary Monsanto were responsible for his Roundup cancer. They ordered the company to pay the man and his wife $289 million in damages, an amount that was later reduced by a judge to $78 million.
In recent weeks, there’s been a tsunami of lawsuits filed against the manufacturers of Zantac and other heartburn drugs containing ranitidine, holding them responsible for their Zantac cancer diagnosis. At the heart of the various complaints is a chemical called N-Nitrosodimethylamine, or NDMA. Victims are saying that NDMA is found in the medication at dangerously high levels and that the manufacturers were aware of its risks but failed to provide consumers with warnings. Let’s take a look at what N-Nitrosodimethylamine is, and why it is so dangerous.
Two years after losing his mother to breast cancer, an Indiana man has filed a wrongful death lawsuit against several Zantac and generic Zantac manufacturers, blaming them for her illness. Guy Tedesco filed the Zantac cancer lawsuit in the U.S. District Court for the Southern District of Florida on May 12th, seeking damages for himself and for his mother, Teresa. According to the claim, Mrs. Tedesco had taken the heartburn medications for over three decades.
In response to reports from the United States regarding the prevalence of Roundup cancer, one of Europe’s leading home improvement stores has decided to discontinue sales of the product. A quick walk through one of B&Q’s stores reveals that the product — as well as all others that are glyphosate-based — are not being restocked, in any size, and a visit to the website reveals only 1 liter bottles being sold, and it’s listed at a deeply discounted clearance price.
Several months ago, the U.S. Food and Drug Administration reported having found traces of a cancer-causing chemical called N-Nitrosodimethylamine , or NDMA, in the popular heartburn medication ranitidine. Ranitidine in the form of Zantac is one of the top-selling drugs in the world, and though the report raised concerns about Zantac cancer, most people continued taking the medication.
The main ingredient in Roundup weed killer, glyphosate, has been blamed for numerous types of cancer and has been named in multiple personal injury lawsuits against its manufacturer, Monsanto. Now the company is poised for an onslaught of additional claims as researchers from Japan’s Chiba University have published research indicating that the chemical may also be behind the development of Parkinson’s Disease.
Imagine taking medication for nearly 15 years to address relentless pain, only to find that it has led to permanent vision loss. That is exactly what Kimberly Pelczar says happened to her. The Connecticut woman has filed an Elmiron vision loss lawsuit against both Teva Pharmaceuticals USA Inc., and Johnson & Johnson’s subsidiary Janssen Pharmaceuticals, accusing both of negligence and responsibility for her eye problems.
Facing an estimated 125,000 Roundup cancer lawsuits, Bayer AG has reportedly reached a verbal agreement with plaintiffs’ attorneys. The agreement is part of a total $10 billion package that would cover between 50,000 and 85,000 of the suits. Bayer AG became the owner of the controversial product in 2018, when it acquired the chemical company, Monsanto. It is expected that the plaintiffs whose lawsuits that are covered by the proposed agreement will see payouts between a few thousand dollars and a few million dollars. Some victims’ attorneys are expected to hold out for more.
Zantac is one of the most popular medications available. Over the last 15 years, the prescription version of the medication has consistently ranked among the top 60 medications prescribed. In 1988 it became the world’s top-selling drug, and it was the first drug to reach over $1 billion in annual sales. But in recent days Zantac’s active ingredient, ranitidine, has been determined to contain high levels of a dangerous carcinogen, the chemical NDMA. Since then the U.S. Food and Drug Administration has requested that the drug be removed from store shelves, and most major retailers have complied.
A Canadian woman who has long suffered from interstitial cystitis found remarkable relief from the condition, but now she is voluntarily returning to her discomfort out of fear of Elmiron vision loss. Carrie Gagno lives in Toronto, Canada. She has been taking Elmiron – also known by its generic name of pentosan polysulfate sodium – for 15 years, ever since her physician prescribed it for the painful bladder syndrome. But now that her physician has learned of its risk and made her aware, she has voluntarily given up the medication.
Danziger & De Llano, LLP. Office Locations: (Principal Office) Houston, Texas . Contact Danziger & De Llano for more information. Prior results do not guarentee or predict a similar outcome with respect to any future matter.